| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/06/2006 | EP1696960A1 Intranasal administration of glucose-regulating peptides |
| 09/06/2006 | EP1696957A2 Radiation therapy and medical imaging using uv emitting nanoparticles |
| 09/06/2006 | EP1696923A2 Nicotine delivery product and method for producing |
| 09/06/2006 | EP1696913A1 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 09/06/2006 | EP1696911A1 Intranasal compositions |
| 09/06/2006 | EP1696886A1 Drug delivery compositions and methods |
| 09/06/2006 | EP1696878A1 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 09/06/2006 | EP1696868A1 Topical skin care composition containing refined peanut oil |
| 09/06/2006 | EP1696784A2 Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof |
| 09/06/2006 | EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/06/2006 | EP1341517B1 A skin cream composition |
| 09/06/2006 | EP1286652B1 Skin protectant spray compositions |
| 09/06/2006 | EP1282642B1 Therapeutic pore-forming peptides |
| 09/06/2006 | EP1227780A4 A stable aqueous dispersion of nutrients |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | EP1162943B1 Non-stinging coating composition |
| 09/06/2006 | EP1112075B1 Compositions for the treatment of male erectile dysfunction |
| 09/06/2006 | CN1829763A Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same |
| 09/06/2006 | CN1829742A Aminated complex-type sugar chain derivatives and process for the production thereof |
| 09/06/2006 | CN1829735A Imaging agents |
| 09/06/2006 | CN1829682A Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents |
| 09/06/2006 | CN1829659A Amorphous silica particles having high absorbing capabilities and high structural characteristics |
| 09/06/2006 | CN1829535A Sphingoid polyalkylamine conjugates for vaccination |
| 09/06/2006 | CN1829514A CCI-779 lyophilized formulations |
| 09/06/2006 | CN1829510A Dispersible formulation of an anti-inflammatory agent |
| 09/06/2006 | CN1829503A Veterinary aqueous injectable suspensions containing florfenicol |
| 09/06/2006 | CN1829500A Improved stearate composition and preparation method |
| 09/06/2006 | CN1829498A Lipid particles having asymmetric lipid coating and method of preparing same |
| 09/06/2006 | CN1829494A Cosmetic patch and using method thereof, and cosmetic patch package |
| 09/06/2006 | CN1829449A Masticatable capsule and process for producing the same |
| 09/06/2006 | CN1828292A Method for determining capsaicin flexible liposome encapsulation rate using dextran microgel column |
| 09/06/2006 | CN1827171A Method for preparing capsaicin carrier |
| 09/06/2006 | CN1827150A Externally applied emulsion film for treating rheumatic and rheumatoid disease and its preparing method |
| 09/06/2006 | CN1827105A Foaming agent for treating gynecological disease and method for preparing the same |
| 09/06/2006 | CN1827096A Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof |
| 09/06/2006 | CN1827094A Gel type dexketoprofen plaster and method for preparing the same |
| 09/06/2006 | CN1273589C Conjugation of polypeptides |
| 09/06/2006 | CN1273195C Carbonized pollen and its application in preparation of cancer-treating medicine |
| 09/06/2006 | CN1273194C Oral solid solution formulation of a poorly water-soluble active substance |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273187C Zinc-free or low-zinc preparation with improved stability |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273138C Sustained-release preparations of quinolone antibiotics and preparation method thereof |
| 09/06/2006 | CN1273135C Pharmaceutical composition of N-methyl-D-aspartate receptor agonist |
| 09/06/2006 | CN1273120C Parasiticidal composition and methods of use |
| 09/06/2006 | CN1273117C Controlled-releasing sticking plaster of natural interferon |
| 09/06/2006 | CN1273113C Powder processing with pressurized gaseous fluids |
| 09/06/2006 | CN1273112C Fibrate-statin combinations with food-reducing and -fasting function |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | USRE39264 Pharmaceutical combination |
| 09/05/2006 | US7102024 Functional biopolymer modification reagents and uses thereof |
| 09/05/2006 | US7102019 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101967 Drug delivery; peptide carrier is linked via oligonucleotides, nucleotides, proteins, or peptides to drugs (anticancer agents, antitumor agents- paclitaxel and/or popdphyllotoxin) |
| 09/05/2006 | US7101932 Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol) |
| 09/05/2006 | US7101928 Polymeric thickeners for oil-containing compositions |
| 09/05/2006 | US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101842 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 09/05/2006 | US7101840 Polymeric drug formulations |
| 09/05/2006 | US7101837 Recombinant human alpha-fetoprotein as a cell proliferative agent |
| 09/05/2006 | US7101693 Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 09/05/2006 | US7101576 Nanoparticles of megestrol, megestrol acetate, or a salt and a stabilizer is assocated with the surface of the nanoparticle |
| 09/05/2006 | US7101574 Pharmaceutical composition containing fenofibrate and the preparation method |
| 09/05/2006 | US7101572 Taste masked aqueous liquid pharmaceutical composition |
| 09/05/2006 | US7101568 Biodegradation organophosphorus polymer; administering to tumor in situ |
| 09/05/2006 | US7101566 Polymer coated microparticles for sustained release |
| 09/05/2006 | US7101564 Plastically deformable implant |
| 09/05/2006 | US7101560 Combination vaccine for administration to adolescents |
| 09/05/2006 | US7101557 Promoting coagulation in prothrombotic blood vessels, treating a vascularized tumor with a coagulation-deficient tissue factor compound |
| 09/05/2006 | US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/05/2006 | US7101552 Preferential particle for inducing immume respone to viral disease and lymphadenopathy associated viruses |
| 09/05/2006 | US7101546 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
| 09/05/2006 | US7101543 Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells |
| 09/05/2006 | CA2412885C Porous celecoxib matrices and methods of manufacture thereof |
| 09/05/2006 | CA2246668C Low ph germicidal iodine compositions having enhanced stability |
| 08/31/2006 | WO2006090968A1 Composition for adjuvant containing poly-gamma-glutamic acid |
| 08/31/2006 | WO2006090924A1 Block copolymer having peptide ligand |
| 08/31/2006 | WO2006090839A1 Medicine for external application containing anti-inflammatory agent and soy lecithin |
| 08/31/2006 | WO2006090833A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 08/31/2006 | WO2006090824A1 Gel composition and method for producing same |
| 08/31/2006 | WO2006090816A1 Method of constructing liposome vaccine |
| 08/31/2006 | WO2006090813A1 Element retained in blood showing degradability selectively in tumor tissue |
| 08/31/2006 | WO2006090782A1 Composition for hydrous adhesive patch for external use and adhesive patch comprising the composition |
| 08/31/2006 | WO2006090640A1 Tablet composition containing amino acid and process for producing tablet |
| 08/31/2006 | WO2006090544A1 Chewable tablet containing collagen peptide and process for producing the same |
| 08/31/2006 | WO2006090365A2 Polysaccharide-oligoamine conjugates as anti-amyloid and anti-viral agents |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006090127A1 Pharmaceutical formulation |
| 08/31/2006 | WO2006089953A1 Compounds for stabilizing factor vii polypeptide formulations |
| 08/31/2006 | WO2006089804A1 Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 08/31/2006 | WO2006089668A1 Transport of nano- and macromolecular structures into cytoplasm and nucleus of cells |
| 08/31/2006 | WO2006089656A2 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 08/31/2006 | WO2006089537A1 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies |
| 08/31/2006 | WO2006072685A3 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 08/31/2006 | WO2006061155A3 Stabilisation of glucocorticoid esters with acids |
| 08/31/2006 | WO2006059029A3 Solutions viscoelastiques renfermant du hyaluronate de sodium et de l ' hydroxypropylmethylcellulose |
| 08/31/2006 | WO2006048452A3 Peptides for use in treating of obesity |
| 08/31/2006 | WO2006048450A3 Peptides for use in the treating obesity |
| 08/31/2006 | WO2006044908A3 Antibody formulation in histidine-acetate buffer |